FILIP JANKU to Histiocytosis, Langerhans-Cell
This is a "connection" page, showing publications FILIP JANKU has written about Histiocytosis, Langerhans-Cell.
Connection Strength
1.094
-
A tale of two histiocytic disorders. Oncologist. 2013; 18(1):2-4.
Score: 0.353
-
Response of histiocytoses to imatinib mesylate: fire to ashes. J Clin Oncol. 2010 Nov 01; 28(31):e633-6.
Score: 0.299
-
Histiocytic Neoplasms, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021 11; 19(11):1277-1303.
Score: 0.163
-
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016 06 02; 127(22):2672-81.
Score: 0.110
-
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms. Cancer Discov. 2016 Feb; 6(2):154-65.
Score: 0.107
-
Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era. Blood. 2020 05 28; 135(22):1929-1945.
Score: 0.037
-
Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disorders. Cancer Discov. 2015 Jan; 5(1):64-71.
Score: 0.025